|MR Angiography: Function and New
458. Design and Construction of a Robust Flow Phantom for the ISMRM
Flow and Motion Group
Multi-Centre Trial, P. Summers, D.W. Holdsworth, H. Nikolov, Y. Papaharilou and B.K. Rutt, King's College and Imperial College, London, UK and John P. Robarts Research Institute, London, Ontario, Canada.
|10:42 459. Evaluation of Vascular Function Using Phase Contrast Based MRI; Reproducibility and Repeatability, M.S. Hansen, H.G. Flaagoy, K. Sorensen, S. Oyre and E.M. Pedersen, Aarhus University Hospital, Aarhus, Denmark.|
|10:54 460. Quantification of Aortic and Mitral Regurgitation Using Heart Motion Adapted Cine Phase Contrast Flow Measurements, S. Kozerke, J. Schwitter, E.M. Pedersen and P. Boesiger, University and ETH and University Hospital, Zurich, Switzerland and Aarhus University Hospital, Aarhus, Denmark.|
|11:06 461. MR Clearance Measurements Predict Hemodynamically Significant Renal Artery Stenosis Following Angiotension Converting Enzyme (ACE) Inhibition, T.M. Grist, O. Unal, R.A. Omary, D. Koscielski, E.R. Niendorf, R. Frayne and F.R. Korosec, University of Wisconsin, Madison, WI, USA.|
|11:18 462. Rose Model in MRI: Noise Limitation on Spatial Resolution and Implications for Contrast Enhanced MR Angiography, R. Watts, Y. Wang, P.A. Winchester, N. Khilnani and L. Yu, Weill Medical College of Cornell University, New York, NY, USA.|
|11:30 463. Embedded MR Fluoroscopy: High Temporal Resolution Real-Time Imaging During High Spatial Resolution 3D MRA Acquisition, S.B. Fain, R.F. Busse, S.J. Riederer and J. Huston III, Mayo Clinic, Rochester, MN, USA.|
|11:42 464. Radial Scanning for Real-time Non-Breath-Hold Pulmonary Angiography: Preliminary Experience for Detection of Pulmonary Embolism, A. Bücker, P. Haage, S. Döhmen, G. Adam, A. Glowinski, T. Schaeffter, S. Weiß, J.J. van Vaals and R.W. Günther, University of Aachen, Aachen, Germany and Philips Research Laboratories, Hamburg, Germany.|
465. Molecular Characterization of Thrombus Using Bimodal ¹H/19F
MR Imaging with a Novel
Fibrin-Targeted Nanoparticulate Contrast Agent, X. Yu, S-K. Song, M.J. Scott, R.J. Fuhrhop, G.M. Lanza, C.S. Hall and S.A. Wickline, Washington University, St. Louis, MO, USA.
|12:06 466. Intra-Arterial Contrast Enhanced MRA (IA-CEMRA), D.J. Taylor and G. Brown, Royal Adelaide Hospital, Adelaide, Australia.|
|12:18 467. Steady State and First Pass Blood Pool Agent Contrast Enhanced MRA, W.J. Niessen, A.D.M. van Swijndregt, B.H.P. Elsman, O. Wink, M.A. Viergever and W.P.T.M. Mali, University Medical Center, Utrecht, the Netherlands.|
Return to ISMRM program